non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease mortality risk can be predicted using the steatosis, activity, and fibrosis (SAF) score. It is well known that patients with non-alcoholic fatty liver disease (NAFLD) are at a higher risk of death, so researchers and doctors have been long searching for a way to predict mortality. Finally, a scoring system has ...click here to read more

Fibrosis risk may be reduced with coffee consumption in fatty liver disease patients. The growing rates of diabetes, obesity, and metabolic syndrome resulted in the greater prevalence of non-alcoholic fatty liver disease (NAFLD), which is becoming the leading cause of chronic liver disease. In some patients, NAFLD progresses into its extreme form, nonalcoholic steatohepatitis (NASH), ...click here to read more

A detailed study presented at The International Liver Congress 2016 in Barcelona, shows that exenatide – a diabetes drug that gets the pancreas to improve glucose absorption – also helps increase glucose uptake and reduce insulin resistance in fatty cells (adipose tissue) and in the livers of NAFLD patients. Non-alcoholic fatty liver disease (NAFLD) is ...click here to read more

Previously, it was believed that only drinkers developed liver disease, but with the rise of non-alcoholic fatty liver disease (NAFLD) it seems that alcohol isn’t the number one threat to your liver. Because the name itself – non-alcoholic fatty liver disease – implies fat, many lean people believe they are safe from the condition – ...click here to read more

Many of us still believe that alcohol, and alcohol alone, is the real threat to our livers. However, alcoholic fatty liver disease is slowly declining and giving way to a more threatening type of liver condition. Non-alcoholic fatty liver disease (NAFLD) is growing to become the number one type of liver disease. Worse yet, it ...click here to read more